In this guide
What is Manuka honey?
Manuka honey comes mainly from nectar of Leptospermum scoparium. Labels may report methylglyoxal (MGO) or a Unique Manuka Factor (UMF) grade, but a higher number does not establish a clinical benefit from eating the product.
It is useful to separate three categories: an ordinary food, a study-specific oral product and a sterile medical-grade wound product. Findings from one category should not be copied to another.
Typical Manuka Honey Protocols
| Source and context | Material | Amount | Frequency | Duration | Observed result |
|---|---|---|---|---|---|
| Wallace 2010 · 20 healthy adults | UMF 20.3 Manuka honey and multifloral control honey in crossover periods | 20 g/day, split into two 10 g doses | 2 administrations daily | 4 weeks per honey, with 2-week washout | No change in measured IgE, CML or selected gut microbial groups A small safety study, not an efficacy trial for digestive disease. |
| Fogh 2017 · 163 people receiving concurrent chemoradiation for lung cancer | Irradiated UMF 16 Manuka honey as liquid or dehydrated lozenges | 10 mL liquid or 2 lozenges equal to 10 mL per administration | 4 times daily over about 12 hours | During concurrent chemoradiation | No significant week-4 swallowing-pain benefit versus supportive care 53 supportive care, 54 liquid and 56 lozenge assignments in the abstract; full PMC methods were read. |
| Jull 2008 · 368 people with venous leg ulcers | Calcium-alginate dressings impregnated with Manuka honey | Dressing exposure; no oral dose | Topical schedule not reported in the abstract | 12 weeks | 55.6% healed versus 49.7% with usual care; difference not significant All participants received compression bandaging; honey was associated with more adverse events. |
There is no RDA, AI or UL for Manuka honey. These study regimens are not a general dosing range.
- Route
- Record oral food, lozenge, rinse or medical dressing separately.
- Grade
- Record UMF or MGO value, batch and whether the product is sterile medical grade.
- Frequency
- Wallace split 20 g/day into two doses; Fogh used four administrations daily.
- Stopping
- Stop oral use for allergic symptoms or unacceptable glucose effects; seek wound care for infection or deterioration.
Three checks before comparing
Keep the route, product grade and clinical comparator attached.
Eating honey is different from placing a dressing on a wound.
Medical-grade products are sterilized and quality controlled.
Supportive care and compression remain active treatment contexts.
What is Manuka honey commonly used for?
People eat it as a sweetener or use it for throat comfort and market it for digestion or immunity. Clinicians may use regulated medical-grade honey dressings in selected wound-care settings. The three trials here do not establish a general oral digestive, immune, cancer-treatment or wound-healing benefit.
Which forms and labels matter?
Jarred honey is a food. UMF and MGO describe chemical or authenticity-related properties, not sterility or guaranteed efficacy. Medical-grade dressings are processed and packaged for clinical use. Lozenges and liquids used in oncology trials also have product-specific handling.
Record grams or millilitres per administration, total daily amount, UMF/MGO grade, manufacturer, batch, route and whether a product was irradiated or otherwise sterilized. Do not apply kitchen honey to broken skin.
What does the human evidence show?
Wallace 2010 used a randomized double-blind crossover design in 20 healthy adults. Each participant consumed Manuka UMF 20.3 and a multifloral honey for four weeks each, separated by washout. The exact daily exposure was two 10 g doses. Neither honey materially changed measured IgE, carboxymethyl-lysine or selected gut microbial groups. This supports short-term tolerability in that small population, not digestive efficacy. [1]
Fogh 2017 randomized 163 people during lung-cancer chemoradiation to supportive care, liquid Manuka honey or Manuka lozenges. The active regimens supplied 10 mL four times daily, either liquid or as two lozenges, over about 12 hours. Swallowing-pain change at week 4 did not differ significantly. One secondary opioid-use comparison favored liquid honey, but the negative primary endpoint prevents a broad prevention claim. [2]
Jull 2008 randomized 368 people with venous leg ulcers to Manuka-honey alginate dressings or usual dressings; everyone received compression. At 12 weeks, 55.6% versus 49.7% had healed, a nonsignificant difference. Honey treatment was associated with more adverse events. This strong null comparator matters when topical marketing implies guaranteed healing. [3]
How might Manuka honey work?
Honey has high osmolarity, acidity and peroxide-related activity. Manuka honey also contains methylglyoxal and other constituents that contribute to laboratory antimicrobial activity. Direct contact at a wound surface differs from digestion and metabolism after swallowing. Mechanistic plausibility cannot substitute for route-specific clinical outcomes.
What are the risks and interactions?
Honey is rich in sugars and can affect carbohydrate intake and glucose management. Avoid in infants under 12 months because honey can contain Clostridium botulinum spores. Bee-product allergy is possible. Dental exposure and gastrointestinal intolerance may matter with repeated oral dosing.
People with diabetes, swallowing difficulty, active cancer treatment or complex wounds should involve their clinical team. Do not replace compression, debridement, infection assessment or oncologic supportive care with honey. Never use food-grade honey in a wound.
Legal status in the United States and Canada
Food honey and medical wound products follow different regulatory pathways. A food label or UMF/MGO grade does not authorize disease-treatment claims. Use wound products according to their licensed indication and local clinical guidance.
What should be monitored?
Track product grade, form, batch, grams or millilitres per administration, frequency, meals, glucose when relevant, oral irritation, allergy symptoms and the exact clinical outcome. Wounds require clinician-defined measures such as area, drainage, infection signs and compression adherence.
What happens after stopping?
No withdrawal syndrome or taper is established. Oral sugar exposure ends when use stops. Wound therapy should change only within a clinician-directed plan.
How should Manuka honey be stored?
Follow the label, close food containers, protect them from contamination and excessive heat, and keep them away from infants. Medical dressings must remain in intact sterile packaging until use.
Community experiences
Reports often combine throat soothing, digestive claims and wound use. They can describe taste or tolerability, but cannot establish sterility, glucose safety, infection control or healing efficacy.
How does Manuka honey compare with other approaches?
For a sore throat, ordinary honey may also soothe, so a premium grade is not automatically necessary. For venous ulcers, compression and professional wound assessment remain the treatment context. During chemoradiation, prescribed supportive care takes priority.
Frequently asked questions
Is UMF 20 a proven oral therapeutic dose?
No. UMF is a grade, and the Wallace study was a small safety crossover rather than proof of disease treatment. [1]
Was 20 g/day taken once daily?
No. The full methods specify two 10 g doses each day. [1]
Did Manuka honey prevent chemoradiation esophagitis?
No significant primary swallowing-pain benefit was found at week 4. [2]
Did the large venous-ulcer trial show faster healing?
No. The 12-week healing difference was not statistically significant, and adverse events were more common with honey. [3]
Can jarred honey be used on an open wound?
No. Food honey is not a sterile medical dressing.
Is it suitable for infants?
No honey should be given to infants under 12 months.
Does a higher MGO number guarantee a better outcome?
No. It does not replace route-specific clinical evidence.
Glossary
Terms used in this guide.
- MGO
- Methylglyoxal, one contributor to Manuka honey's non-peroxide antimicrobial activity.
- UMF
- A proprietary grading system based on specified Manuka-honey markers.
- Medical-grade honey
- Honey processed, quality controlled and packaged for clinical use.
- Crossover trial
- A study in which participants receive more than one intervention in sequence.
- Primary endpoint
- The outcome designated in advance as the main test of a trial.
- Compression therapy
- A core treatment context for many venous leg ulcers.
How this guide was researched
This draft prioritizes a full-method oral safety study, a full open oncology trial and a large randomized wound-dressing trial. Evidence was updated October 9, 2026.
How this guide was made
The ledger preserves route, product grade, sterilization, per-administration amount, frequency, duration, comparator, primary result and adverse-event context.
Method and gaps
All three PubMed records were compared with live NCBI efetch XML for titles, authors, journals, DOI values and CommentsCorrections. Fogh 2017 full open PMC methods and results and Wallace 2010 publisher methods were read. Jull 2008 protocol detail is limited to the PubMed abstract.
Gaps: replicated oral efficacy trials, direct pharmacokinetics after eating Manuka honey, product-independent comparisons, pregnancy and lactation, pediatric use beyond the established infant honey avoidance, and long-term glucose effects.
Sources
Inspect the oral safety, oncology and wound-dressing trials.
Showing 3 sources
- 01
Demonstrating the safety of manuka honey UMF 20+in a human clinical trial with healthy individuals. ↗
Randomized double-blind crossover safety trial
20 healthy adults; 20 g/day as two 10 g doses for four weeks per honey, with a two-week washout.
- 02
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. ↗
Randomized phase 2 supportive-care trial
163 randomized; 10 mL liquid or two lozenges equivalent to 10 mL four times daily; primary week-4 pain result was null.
- 03
Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. ↗
Open-label randomized controlled wound trial
368 participants; Manuka-honey alginate or usual dressing plus compression for 12 weeks; healing difference was not significant.
No matching sources
Try a different term or show the full list.